Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer

NCT00975455 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1400

Last updated 2011-06-08

No results posted yet for this study

Summary

The purpose of the study is to evaluate subjects with gross or microscopic hematuria undergoing scheduled cystoscopy to determine the absence or presence of bladder cancer.

Conditions

  • Microscopic or Gross Hematuria

Sponsors & Collaborators

  • Predictive Biosciences

    lead INDUSTRY

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-11-30
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00975455 on ClinicalTrials.gov